Price
No data yet.
Social Signal Score
Analyst Ratings
Revenue
$2.46B-9.20%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Charles V. Magro
- Sector
- Basic Materials
- Industry
- Agricultural Inputs
- Employees
- 21,500
- Beta
- 0.60
- Country
- US
Financials
VYLR has only 4 quarterly periods on file — the charts below show the full history available.
Revenue
$2.46B-9.2%Net Income
$-570.00M-243.6%EBITDA
$-514.00M-170.2%Free Cash Flow
$353.00MEPS (diluted)
$-0.85-241.7%Shares Outstanding (diluted)
667.80M+0.1%Operating Expenses
$1.13BCash & Debt
$3.93BDividend per Share
$0.13Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $10.07B | $376.00M | $0.56 |
| 2024 | $9.54B | $772.00M | $1.16 |
| 2023 | $9.47B | $652.00M | $0.98 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from VYLR's reported EPS growth of -24.4% a year over 2 years. Historical EPS growth of -24% would project the company towards zero. Floored at -15% as a starting point.
- EPS in 5 years
- $0.25
- Implied price
- $4.50
- Return from $69.82
- -42.2% a year
To earn 15.0% a year on these assumptions you'd need to buy at $2.24 — -96.8% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 12 | 15 | 18 | 21 | 24 |
|---|---|---|---|---|---|
| -25.0% | -53.0% | -50.8% | -49.0% | -47.4% | -46.0% |
| -20.0% | -49.8% | -47.6% | -45.6% | -43.9% | -42.4% |
| -15.0% | -46.7% | -44.3% | -42.2% | -40.4% | -38.8% |
| -10.0% | -43.6% | -41.0% | -38.8% | -36.9% | -35.2% |
| -5.0% | -40.4% | -37.7% | -35.4% | -33.4% | -31.6% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
50-54.55%Social Signal Score
Mentions (10)
- News (RSS)businessinsider·27d ago·Neutral
Vylor Inc. declares $0.13 dividend
View source ↗ - News (RSS)investing·31d ago·Neutral
Vylor authorizes $3 billion share repurchase program
View source ↗ - Newsprnewswire.com·31d ago·Positive
Vylor Announces $3 Billion Share Repurchase Program Reflects Company's Focus on Long-Term Value Creation JOHNSTON, Iowa, Oct. 22, 2026 /PRNewswire/ -- Vylor (NYSE: VYLR) today announced that its Board of Directors, at its quarterly meeting, authorized a new, multi-year $3 billion share repurchase program, consistent with the capital allocation strategy outlined at the Company's Investor Day on September 15, 2026. Under the share repurchase program, which is immediately effective and does not exp…
View source ↗ - Newsprnewswire.com·31d ago·Neutral
Vylor Declares Quarterly Dividend JOHNSTON, Iowa, Oct. 22, 2026 /PRNewswire/ -- Vylor (NYSE: VYLR) today announced that its Board of Directors, at its quarterly meeting, authorized a common stock dividend of $0.13 cents per share, payable December 7, 2026, to the Company's shareholders of record on November 30, 2026. About Vylor Vylor is an advanced seed and genetics company that has, for more than a century, been focused on delivering groundbreaking innovation to farmers.
View source ↗ - News (RSS)seekingalpha·40d ago·Neutral
Vylor: A Food Scarcity Play With Growth Optionality
View source ↗ - Newsseekingalpha.com·40d ago·Positive
Vylor: A Food Scarcity Play With Growth Optionality Vylor Inc. is rated 'Buy,' considering that it's an excellent proxy for the food security investment theme. Yield-enhancement technologies position VYLR to benefit from food demand trends, while settlement with Bayer unlocks incremental licensing income. VYLR currently targets a 7%-8% annualized EBITDA CAGR and 300bps margin expansion through FY26-29, with potential upside from hybrid wheat and biofuel ventures.
View source ↗ - News (RSS)seekingalpha·47d ago·Positive
Corteva upgraded at J.P. Morgan following spinoff of Vylor
View source ↗ - News (RSS)zerohedge·47d ago·Neutral
…a and New Jersey. Corteva Inc. (CTVA) is up 3% after JPMorgan raised its recommendation on the crop chemical company to overweight from neutral after it spun off its Vylor Inc. seed business. JetBlue Airways (JBLU) gains 2.1% after Citi upgraded the airline to neutral from sell. Option Care Health (OPCH) rises 21% after the Financial Times reports that McKesson and PE firm Clayton Dubilier & Rice are closing in on a deal to buy the provider of medical infusion services, in a transaction that wou…
View source ↗ - 4chan /biz/biz·52d ago·Neutral
>>62745737 VYLR innit
View source ↗ - 4chan /biz/biz·52d ago·Positive
>>62745732 would you buy CVTA, or VYLR?
View source ↗
Earnings
Thu, Feb 11(in 3 months)
Consensus estimate $-0.03 per share
Typical surprise +21.1% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Nov 11$-0.42 vs $-0.53beat
Estimates and results for VYLR via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by VYLR officers and directors.
No open-market trades in the recent filings. All 58 recent Form 4 entries were share awards, option exercises or tax withholding — pay, not decisions to buy or sell.
58 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in VYLR.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
